1-3 of 3
Julie Erb-Alvarez
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Trial in Progress: A Phase I/II Study of the JAK1/2 Inhibitor Ruxolitinib for Relapsed/Refractory Immune Bone Marrow Failure

Emma M. Groarke, Jennifer Lotter, Ivana Darden, Alfiya Bikineyeva, Uzoamaka Okeke, Rachel Blair, Julie Erb-Alvarez, Jichun Chen, Xingmin Feng, Jibran Durrani, Neal S. Young, Bhavisha A. Patel
Journal: Blood
Blood (2024) 144 (Supplement 1): 1323.1.
https://doi.org/10.1182/blood-2024-199789
Published: 2024
Journal Articles

Prospective Phase I/II Study of Eltrombopag for the Treatment of Bone Marrow Failure in Fanconi Anemia

Ma Evette Barranta, Fariba Chinian, Katherine Roskom, Tarik Lott, Julie Erb-Alvarez, Katherine R. Calvo, Thomas Winkler, Neelam Giri, Andre Larochelle
Journal: Blood
Blood (2021) 138 (Supplement 1): 2177.
https://doi.org/10.1182/blood-2021-148573
Published: 2021
Journal Articles

Phase II Study of Eltrombopag in Subjects with Fanconi Anemia

Daisuke Araki, MD, Ma Evette Barranta, Fariba Chinian, MS, Julie Erb-Alvarez, MPH, Thomas Winkler, MD, Neelam Giri, MD, Andre Larochelle, MD PhD
Journal: Blood
Blood (2019) 134 (Supplement_1): 3753.
https://doi.org/10.1182/blood-2019-123151
Published: 2019